Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel Free ENTO Stock Alerts

Entero Therapeutics (ENTO) SEC Filings & 10K Form

Entero Therapeutics logo
$2.28 +0.13 (+6.05%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$2.20 -0.08 (-3.51%)
As of 08/29/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Entero Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/26/2025
3:06 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRE 14A
08/18/2025
5:56 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Sawyer Jason David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/18/2025
5:58 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Pursglove Geordan Garrett (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/18/2025
9:40 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/15/2025
4:09 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025
9:59 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2025
8:01 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2025
3:53 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
3:16 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2025
4:16 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
06/23/2025
3:06 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
06/10/2025
8:30 PM		Ali Arif Nasir (Filed by)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics (Subject)
Form SCHEDULE 13D/A
06/09/2025
8:55 PM		Ali Arif Nasir (Filed by)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics, Inc. (Subject)
Entero Therapeutics (Subject)
Form SCHEDULE 13D
06/05/2025
4:23 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-1/A
06/04/2025
3:05 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEF 14A
05/30/2025
4:25 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
05/27/2025
5:09 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
05/16/2025
4:04 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRE 14A
05/15/2025
12:20 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/14/2025
3:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
4:21 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-K/A
04/01/2025
10:06 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-K
02/13/2025
3:59 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Paolone Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:00 PM		Corbett Eric (Reporting)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:02 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Uppal Manpreet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
3:31 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:18 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:23 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:15 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
6:31 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
4:00 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:10 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ENTO) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
An MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...
True Market Insiders | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...
The Oxford Club | Sponsoredtc pixel
A Major Economic Change Is Happening Now
Louis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...
InvestorPlace | Sponsoredtc pixel
“HELIOS”: My No. 1 Investment of the 2020s
A mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...
Stansberry Research | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...
Brownstone Research | Sponsoredtc pixel